SCHEMBL30786359

SCHEMBL30786359

O=[N+]([O-])c1cc(CO)cc(B(O)O)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ENPP2 Q13822 1/20 0.43
TSHR P16473 3/20 0.38
CYP19A1 P11511 1/20 0.38
TTR P02766 2/20 0.37
MEN1 O00255 2/20 0.36
HTT P42858 2/20 0.36
KMT2A Q03164 2/20 0.36
LMNA P02545 1/20 0.36
CYP3A4 P08684 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
ALDH1A1 P00352 2/20 0.34
POLB P06746 1/20 0.34
KDM4E B2RXH2 1/20 0.34
CYP1A2 P05177 1/20 0.34
MAPT P10636 1/20 0.34
CYP2C9 P11712 1/20 0.34
HPGD P15428 1/20 0.34
ALOX15 P16050 1/20 0.34
ALOX12 P18054 1/20 0.34
MAPK1 P28482 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18883021 1.00 ENPP2 (0.43) ENPP2TSHRCYP19A1TTRMEN1
SCHEMBL561018 0.82 CYP19A1 (0.48) TSHRCYP19A1TTRMEN1HTT
SCHEMBL716259 0.82 CYP19A1 (0.54) TSHRCYP19A1TTRMEN1HTT
SCHEMBL6330190 0.82 CYP19A1 (0.54) TSHRCYP19A1TTRMEN1HTT
SCHEMBL3781044 0.76 ENPP2 (0.60) ENPP2TSHRKDM4E
SCHEMBL30319435 0.76 TSHR (0.56) TSHRCYP19A1TTRMEN1HTT
SCHEMBL12265205 0.76 ALDH1A1 (0.47) TSHRCYP19A1TTRMEN1HTT
SCHEMBL31347504 0.76 ACHE (0.54) TSHRCYP19A1TTRMEN1HTT
SCHEMBL11025268 0.76 ACHE (0.54) TSHRCYP19A1TTRMEN1HTT
SCHEMBL18407603 0.76 TSHR (0.56) TSHRCYP19A1TTRMEN1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117486813-A N-disubstituted phenyl acrylamide compound, and pharmaceutical composition and application thereof 江南大学 2024-02-02 CN disclosed